Aripiprazole effects on alcohol consumption and subjective reports in a clinical laboratory paradigm - Possible influence of self-control

Alcoholism: Clinical and Experimental Research

Volumn 32, Issue 11, 2008, Pages 1954-1961

  Voronin, Konstantin ^a,c   Randall, Patrick ^a   Myrick, Hugh ^a,b   Anton, Raymond ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Alcohol; Aripiprazole; Laboratory; Treatment

Indexed keywords

ALCOHOL; ARIPIPRAZOLE; PLACEBO;

ADULT; ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ALCOHOLISM; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DEPRESSION; DOUBLE BLIND PROCEDURE; DRINKING BEHAVIOR; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; IMPULSIVENESS; INSOMNIA; MALE; NERVOUSNESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SELF CONTROL; SIDE EFFECT; SLEEP DISORDER;

ADULT; AFFECT; ALCOHOL DRINKING; ALCOHOLISM; ANTIPSYCHOTIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMPULSIVE BEHAVIOR; MALE; MODELS, THEORETICAL; PIPERAZINES; QUINOLONES; SLEEP; SOCIAL CONTROL, INFORMAL;

EID: 54249113628     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2008.00783.x     Document Type: Article

References (57)

1. Anckarsater H (2006) Central nervous changes in social dysfunction: autism, aggression, and psychopathy. Brain Res Bull 69 : 259 265.
2. Anton RF (1996) New methodologies for pharmacologic treatment trials for alcohol dependence. Alcohol Clin Exp Res 20 : 3A 9A.
3. Anton RF, Drobes DJ, Voronin K, Durazo-Avizu R, Moak D (2004a) Naltrexone effects on alcohol consumption in a clinical laboratory paradigm: temporal effects of drinking. Psychopharmacology (Berl) 173 : 32 40.
4. Anton RF, Kranzler H, Breder C, Marcus RN, Carson WH, Han J (2008) A randomized, multicenter, double-blind, placebo-controlled study of the efficacy and safety of aripiprazole for the treatment of alcohol dependence. J Clin Psychopharmacol 28 : 5 12.
5. Anton RF, Moak DH, Latham PK (1996) The obsessive compulsive drinking scale (OCDS): a new method of assessing outcome in alcoholism treatment studies. Arch Gen Psychiatry 53 : 225 231.
6. Anton RF, Moak DH, Latham PK, Waid LR, Myrick H, Voronin K, Thevos A, Wang W, Woolson R (2005) Naltrexone combined with either cognitive behavioral or motivational enhancement therapy for alcohol dependence. J Clin Psychopharmacol 25 : 1 9.
7. Anton RF, Moak DH, Waid LR, Latham PK, Malcolm RJ, Dias JK (1999) Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial. Am J Psychiatry 156 : 1758 1764.
8. Anton RF, Swift RM (2003) Current pharmacotherapies of alcoholism: a U.S. perspective. Am J Addict 12 : S52 S68.
9. Anton RF, Voronin K, Drobes DJ, Moak DH, Myrick H (2004b) A short-term dosing and bar-lab alcohol administration paradigm for evaluating medications (naltrexone, gabapentin, ondansetron) for alcoholism treatment. Alcohol Clin Exp Res 28 : 177A.
10. Bechara A (2005) Decision making, impulse control and loss of willpower to resist drugs: a neurocognitive perspective. Nat Neurosci 8 : 1458 1463.
11. Beresford TP, Clapp L, Martin B, Wiberg JL, Alfers J, Beresford HF (2005) Aripiprazole in schizophrenia with cocaine dependence: a pilot study. J Clin Psychopharmacol 25 : 363 366.
12. Bohn MJ, Krahn DD, Staehler BA (1995) Development and initial validation of a measure of drinking urges in abstinent alcoholics. Alcohol Clin Exp Res 19 : 600 606.
13. Burris KD, Molski TF, Xu C, Ryan E, Tottori K, Kikuchi T, Yocca FD, Molinoff PB (2002) Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors. J Pharmacol Exp Ther 302 : 381 389.
14. Davis LJ Jr., Hurt RD, Morse RM, O'Brien PC (1987) Discriminant analysis of the self-administered alcoholism screening test. Alcohol Clin Exp Res 11 : 269 273.
15. DeLeon A, Patel NC, Crismon ML (2004) Aripiprazole: a comprehensive review of its pharmacology, clinical efficacy, and tolerability. Clin Ther 26 : 649 666.
16. Drobes DJ, Anton RF (2000) Drinking in alcoholics following an alcohol challenge research protocol. J Stud Alcohol 61 : 220 224.
17. Drobes DJ, Anton RF, Thomas SE, Voronin K (2003) A clinical laboratory paradigm for evaluating medication effects on alcohol consumption: naltrexone and nalmefene. Neuropsychopharmacology 28 : 755 764.
18. Drobes DJ, Anton RF, Thomas SE, Voronin K (2004) Effects of naltrexone and nalmefene on subjective response to alcohol among non-treatment seeking alcoholics and social drinkers. Alcohol Clin Exp Res 28 : 1362 1370.
19. Feltenstein MW, Altar CA, See RE (2007) Aripiprazole blocks reinstatement of cocaine seeking in an animal model of relapse. Biol Psychiatry 61 : 582 590.
20. First MB, Spitzer RL, Gibbon M, Williams JBW (1997) Structured Clinical Interview for DSM-IV Axis I Disorders. American Psychiatric Press, Inc., Washington, DC.
21. Gonzales RA, Weiss F (1998) Suppression of ethanol-reinforced behavior by naltrexone is associated with attenuation of the ethanol-induced increase in dialysate dopamine levels in the nucleus accumbens. J Neurosci 18 : 10663 10671.
22. Grüsser SM, Wrase J, Klein S, Hermann D, Smolka MN, Ruf M, Weber-Fahr W, Flor H, Mann K, Braus DF, Heinz A (2004) Cue-induced activation of the striatum and medial prefrontal cortex is associated with subsequent relapse in abstinent alcoholics. Psychopharmacology (Berl) 175 : 296 302.
23. Ingman K, Kupila J, Hyytia P, Korpi ER (2006) Effects of aripiprazole on alcohol intake in an animal model of high-alcohol drinking. Alcohol Alcohol 41 : 391 398.
24. Katner SN, Weiss F (1999) Ethanol-associated olfactory stimuli reinstate ethanol-seeking behavior after extinction and modify extracellular dopamine levels in the nucleus accumbens. Alcohol Clin Exp Res 23 : 1751 1760.
25. Keck PE, Calabrese JR, McQuade RD, Carson WH, Carlson BX, Rollin LM, Marcus RN, Sanchez R, Group AS (2006) A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder. J Clin Psychiatry 67 : 626 637.
26. Koob GF, Le Moal M (2001) Drug addiction, dysregulation of reward, and allostasis. Neuropharmacology 24 : 97 129.
27. Koob GF, Roberts AJ (1999) Brain reward circuits in alcoholism. CNS Spectr 4 : 23 37.
28. Kranzler HR, Covault J, Pierucci-Lagha A, Chan G, Douglas K, Arias A, Oncken C (2008) Effects of aripiprazole on subjective and physiological responses to alcohol. Alcohol Clin Exp Res 32 : 573 579.
29. Lapish CC, Seamans JK, Chandler LJ (2006) Glutamate-dopamine cotransmission and reward processing in addiction. Alcohol Clin Exp Res 30 : 1451 1465.
30. Lawler CP, Prioleau C, Lewis MM, Mak C, Jiang D, Schetz JA, Gonzalez AM, Sibley DR, Mailman RB (1999) Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes. Neuropsychopharmacology 20 : 612 627.
31. Li Z, Ichikawa J, Dai J, Meltzer HY (2004) Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain. Eur J Pharmacol 493 : 75 83.
32. Lile JA, Stoops WW, Vansickel AR, Glaser PEA, Hays LR, Rush CR (2005) Aripiprazole attenuates the discriminative-stimulus and subject-rated effects of D-amphetamine in humans. Neuropsychopharmacology 30 : 2103 2114.
33. Lyvers M (2000) "Loss of control" in alcoholism and drug addiction: a neuroscientific interpretation. Exp Clin Psychopharmacol 8 : 225 245.
34. Marder SR, McQuade RD, Stock E, Kaplita S, Marcus R, Safferman AZ, Saha A, Ali M, Iwamoto T (2003) Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials. Schizophr Res 61 : 123 136.
35. Martin CS, Earleywine M, Musty RE, Perrine MW, Swift RM (1993) Development and validation of the biphasic alcohol effects scale. Alcohol Clin Exp Res 17 : 140 146.
36. McNair DM, Loor M, Droppleman LF (1981) Manual for the Profile of Mood States. Educational and Industrial Testing Service, San Diego, CA.
37. Middaugh LD, Bandy A-LE (2000) Naltrexone effects on ethanol consumption and response to ethanol conditioned cues in C57BL/6 mice. Psychopharmacology (Berl) 151 : 321 327.
38. Middaugh LD, Szumlinski KK, Patten YV, Marlowe A-LB, Kalivas PW (2003) Chronic ethanol consumption by C57BL/6 mice promotes tolerance to its interoceptive cues and increases extracellular dopamine, an effect blocked by naltrexone. Alcohol Clin Exp Res 27 : 1892 1900.
39. Miller WR, Zweben A, DiClemente CC, Rychtarik RG (1992) Motivational Enhancement Therapy Manual: A Clinical Research Guide for Therapists Treating Individuals With Alcohol Abuse and Dependence. Project MATCH Monograph Series 2, DHHS Publ. No. (ADM) 92-1894, Alcohol, Drug Abuse, and Mental Health Administration, National Institute on Alcohol Abuse and Alcoholism, Rockville, MD.
40. Myrick H, Anton RF, Li X, Henderson S, Drobes D, Voronin K, George MS (2004) Differential brain activity in alcoholics and social drinkers to alcohol cues: relationship to craving. Neuropsychopharmacology 29 : 393 402.
41. Myrick H, Anton RF, Li X, Henderson S, Randall PK, Voronin K (2008) Effect of naltrexone and ondansetron on alcohol cue-induced activation of the ventral striatum in alcohol-dependent people. Arch Gen Psychiatry 65 : 466 475.
42. O'Malley SS, Krishnan-Saria S, Farren C, Sinha R, Kreek MJ (2002) Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary- adrenocortical axis. Psychopharmacology (Berl) 160 : 19 29.
43. Pantelis C, Yucel M, Wood SJ, Velakoulis D, Sun D, Berger G, Stuart GW, Yung A, Phillips L, McGorry PD (2005) Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. Schizophr Bull 31 : 672 696.
44. Patton JH, Stanford MS, Barratt ES (1995) Factor Structure of the Barratt Impulsiveness Scale. J Clin Psychol 5 : 768 774.
45. Rogers MA, Kasai K, Koji M, Fukuda R, Iwanami A, Nakagome K, Fukuda M, Kato N (2004) Executive and prefrontal dysfunction in unipolar depression: a review of neuropsychological and imaging evidence. Neurosci Res 50 : 1 11.
46. Rosenbloom M, Sullivan EV, Pfefferbaum A (2003) Using magnetic resonance imaging and diffusion tensor imaging to assess brain damage in alcoholics. Alcohol Res Health 27 : 146.
47. Schuckit M (1984) Subjective responses to alcohol in sons of alcoholics and control subjects. Arch Gen Psychiatry 41 : 879 884.
48. Seidman LJ, Valera EM, Makris N (2005) Structural brain imaging of attention-deficit/hyperactivity disorder. Biol Psychiatry 57 : 1263 1272.
49. Singleton EG, Tiffany ST, Henningfield JE (1999) Alcohol Craving Questionnaire (-NOW): Background, Scoring, and Administration (Revised). Intramural Research Program. NIDA, Baltimore, MD.
50. Skinner HA, Allen BA (1982) Alcohol dependence syndrome: measurement and validation. J Abnorm Psychol 91 : 199 209.
51. Sobell LC, Cunningham JA, Sobell MB (1996) Recovery for alcohol problems with and without treatment: prevalence in two population surveys. Am J Public Health 86 : 966 972.
52. Sobell LC, Sobell MB (1992) Timeline followback: a technique for assessing self-reported ethanol consumption, in Measuring Alcohol Consumption: Psychosocial and Biological Methods (Allen J, Litten RZ eds pp 41 72. Humana Press, Totowa.
53. Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM (1989) Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict 84 : 1353 1357.
54. Tapert SF, Cheung EH, Brown GG, Frank LR, Paulus MP, Schweinsburg AD, Meloy MJ, Brown SA (2003) Neural response to alcohol stimuli in adolescents with alcohol use disorder. Arch Gen Psychiatry 60 : 727 735.
55. Warsi M, Sattar SP, Bhatia SC, Petty F (2005) Aripiprazole reduces alcohol use. Can J Psychiatry 50 : 244.
56. Watson TE (1989) Total body water and alcohol levels: updating the fundamentals, in Human Metabolism of Alcoholism (Batt RD, Crow KE eds Vol 1, pp 41 66. CRC Press, Boca Raton, FL.
57. Weiss F, Porrino LJ (2002) Behavioral neurobiology of alcohol addiction: recent advances and challenges. J Neurosci 22 : 3332 3337.